A Country Doctor, MD. What is Going On With Generic Drug Prices? Medpage Today’s KevinMD.com. September 29, 2014. http://www.kevinmd.com/blog/2014/09/going-generic-drug-prices.html.

Buckley GJ, Gostin LO, Ed. Chapter 5: Weaknesses in the Drug Distribution Chain. Countering the Problem of Falsified and Substandard Drugs. Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health, Institute of Medicine. National Academies Press. 2013 May 20. http://www.ncbi.nlm.nih.gov/books/NBK202523/.

Colucci R, Dragoni F, Moretti S. Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases. Oxidative Medicine and Cellular Longevity. 2015:531927. Epub 2015 March 9. doi: 10.1155/2015/631927. http://www.hindawi.com/journals/omcl/2015/631927/.

Cummings Introduces Bill to Reform “Gray Market” Drug Sales. Press Release. Committee on Oversight & Government Reform. May 17, 2013. http://democrats.oversight.house.gov/news/press-releases/cummings-introduces-bill-to-reform-gray-market-drug-sales-2.

Eban K. Painful Prescription: Pharmacy Benefits Managers Make Out Better Than Their Customers. Fortune Magazine via KatherineEban.com. October 2013. http://katherineeban.com/2013/10/23/painful-prescription-fortune-com/.

GovTrack.US. H.R. 1958 (113th): Gray Market Drug Reform and Transparency Act of 2012. https://www.govtrack.us/congress/bills/113/hr1958.

Greene JA. Drug Bust: For 30 Years, Generic Medications Helped Make Health Care Cheaper. Why is Their Cost Surging? Slate. Moneybox Commentary about Business and Finance. November 20, 2014. http://www.slate.com/articles/business/moneybox/2014/11/generic_drug_prices_why_their_prices_are_suddenly_surging.html.

Hupila MK, Smith DL. 5 Common Questions About Generic Drugs. Consumer Health Information Corporation. 2008. http://www.consumer-health.com/services/5CommonQuestionsAboutGenericDrugs.php.

Kane J. Drug Prices Soar as Hospital Suppliers are Forced into ‘Gray Market.’ PBS Newshour. August 29, 2011. http://www.pbs.org/newshour/rundown/drug-prices-soar-as-pharmacists-are-forced-into-gray-market/.

Laddha NC, Dwivedi M, Mansuri MS, et al. Role of oxidative stress and autoimmunity in onset and progression of vitiligo. Experimental Dermatology.2014;23(5):352–353. doi: 10.1111/exd.12372.

Lilly E, et al. Development and Validation of a Vitligo-Specific Quality-of-Life Instrument (VitiQoL). Journal of the American Academy of Dermatology. 2013 Jul;69(1):e11-8. doi: 10.1016/j.jaad.2012.01.038. Epub 2012 Feb 25. http://www.ncbi.nlm.nih.gov/pubmed/22365883.

Krishna GS, et al. Vitiligo Impace Scale: An Instrument to Assess the Psychosocial Burden of Vitiligo. Indian Journal of Dermatology, Venereology, and Leprology. 2013. Volume 79, issue 2, pp. 205-210. Epub 2013 Feb. 22. http://www.ijdvl.com/article.asp?issn=0378-6323;year=2013;volume=79;issue=2;spage=205;epage=210;aulast=Krishna.

Lubell J. Lawmakers Hear Evidence of Gray Market in Shortage Drugs. Amednews.com. August 20, 2012.
http://www.amednews.com/article/20120820/government/308209957/4/.

Marley D. Lack of PBM Transparency harms employers. BenefitsPro. September 25, 2012. http://www.benefitspro.com/2012/09/25/lack-of-pbm-transparency-harms-employers.

National Community Pharmacists Association. Patients’ Pharmacy Access Relies on Fair Pharmacy Reimbursement. http://www.ncpanet.org/advocacy/pharmacyaccess.

Pandya A, et al. Confetti Depigmentation as a Sign of Rapidly Progressing Vitiligo. 2015. Unpublished.

Pharmacists United for Truth and Transparency. FAQs: What is a PBM? http://www.truthrx.org/faqs/.

Salzes C, et al. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool. The Vitiligo Working Group. 2015 VWG Abstract Session.

Sanders B. Medicaid  Generic Drug Price Fairness Act. US Senate.  January 2014.  http://www.sanders.senate.gov/download/s-2948?inline=file.

Shelley S, Contributing Editor. Copay Programs’ Increased Value to Manufacturers is Matched by Rising Criticism. Pharmaceutical Commerce. January 15, 2014.
http://pharmaceuticalcommerce.com/special_report?articleid=27073.

Snook TD, Filipek TM. Pharmacy Benefit Management: Pros and Cons of Various Approaches; One Size Does Not Fit All. Milliman White Paper.  May 2011. http://valuedpharmacyservices.com/wp-content/uploads/2013/10/pharmacy-benefit-management-pros-white-paper.pdf.

Thomas, K. Soaring Ointment Prices are a Dermatologic Mystery. The New York Times. August 9, 2012. http://www.nytimes.com/2012/08/10/business/prescription-skin-creams-jump-in-price.html?_r=0.

Tucker, D. Prices Soar for Some Generic Drugs – Why? CBS Chicago. October 31, 2014. http://chicago.cbslocal.com/2014/10/31/prices-soar-for-some-generic-drugs-why/.

Why the Cost of Generics is Surging. NBC Nightly News with Brian Williams. Aired January 2, 2015. http://www.nbcnews.com/watch/nightly-news-netcast/nightly-news-with-brian-williams-full-broadcast-january-2-379474499567.